Alterations of lipid metabolism in Wilson disease

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Seessle, Jessica ^a   Gohdes, Annina ^a   Gotthardt, Daniel Nils ^a   Pfeiffenberger, Jan ^a   Eckert, Nicola ^a   Stremmel, Wolfgang ^a   Reuner, Ulrike ^b   Weiss, Karl Heinz ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

cholesterol; lipids; liver disease; triglycerides; Wilson Disease

Indexed keywords

CHOLESTEROL; COPPER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENICILLAMINE; TRIACYLGLYCEROL; TRIENTINE; ZINC; LIPID;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; COPPER METABOLISM; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; TRIACYLGLYCEROL BLOOD LEVEL; WILSON DISEASE; ANIMAL; BLOOD; METABOLISM; RAT;

ANIMALIA; RATTUS;

ANIMALS; CHOLESTEROL; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIPID METABOLISM; LIPIDS; MALE; RATS; ZINC;

EID: 79956038116     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-83     Document Type: Article

References (21)

1. Wilson's disease. A Ala AP Walker K Ashkan JS D (Pubitemid 46177228)
2. Pathophysiology and clinical features of Wilson disease. P Ferenci, Metab Brain Dis 2004 19 3-4 229 239 15554419 (Pubitemid 39361185)
3. The Wilson disease gene: spectrum of mutations and their consequences. GR Thomas JR Forbes EA Roberts JM Walshe DW Cox, Nat Genet 1995 9 2 210 217 10.1038/ng0295-210 7626145
4. Cooper transporting P-type ATPases and human diseases. DW Cox SD Moore, J Bioenerg Biomemb 2002 34 5 333 338 10.1023/A:1021293818125 (Pubitemid 36055727)
5. Regional distribution of mutations of the ATB7B gene in patients with Wilson disease: impact on genetic testing. P Ferenci, Hum Genet 2006 120 2 151 159 10.1007/s00439-006-0202-5 16791614 (Pubitemid 44204003)
6. Wilson disease: clinical presentation, treatment and survival. W Stremmel KW Meyerrose C Niederau H Hefter G Kreuzpaintner G Strohmeyer, Ann Intern Med 1991 115 9 720 726 1929042
7. Wilson disease. D Huster, Best Pract Res Clin Gastroenterol 2010 24 5 531 539 10.1016/j.bpg.2010.07.014 20955957
8. Late-onset Wilson's disease. P Ferenci A Czlonkowska U Merle S Ference G Gromadzka C Yurdaydin W Vogel R Bruha HT Schmidt W Stremmel, Gastroenterology 2007 132 4 1294 1298 10.1053/j.gastro.2007.02.057 17433323 (Pubitemid 46627596)
9. Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute virale hepatitis and chronic liver disease. C Vergani G Trovato A Del M Pietrogrande N Dioguardi, J Clin Pathol 1978 31 8 772 778 10.1136/jcp.31.8.772 690242 (Pubitemid 9010949)
10. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of wilson disease. D Huster TD Purnat JL Burkhead M Ralle O Fiehn F Stuckert NE Olson D Teupser S Lutsenko, J Biol Chem 2007 282 11 8343 8355 10.1074/jbc.M607496200 17205981 (Pubitemid 47093558)
11. Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease. E Levy S Brunet F Alvarez E Seidman G Bouchard E Escobar S Martin, Life Science 2007 80 16 1472 1483 10.1016/j.lfs.2007.01.017 (Pubitemid 46399751)
12. The effect of copper deficiency on rat hepatic 3-hydroxy-3-methylglutaryl coenzym A reductase activity. QN Yount DJ McNamara AA Al-Othman KY Lei, J Nut Biochem 1990 1 1 21 27 10.1016/0955-2863(90)90094-2 (Pubitemid 20220367)
13. Wilson disease: not just a cooper disorder. Analysis of Wilson disease model demonstrates the link between cooper and lipid metabolism. D Huster S Lutsenko, Mol Bio Syst 2007 3 1 816 824 (Pubitemid 350115409)
14. Benefical effects of dietary copper supplementation on serum lipids and antioxidant defenses in rats. CM Galhardi YS Diniz HG Rodrigues LA Faine RC Burneiko BO Ribas EL Novelli, Ann Nutr Metab 2005 49 5 283 288 10.1159/000087294 16088091 (Pubitemid 41291549)
15. Treatment of Wilson's disease with zinc IX: Response of serum lipids. JG Brewer V Yuzbasiyan-Gurkan V Johnson, J Lab Clin Med 1991 118 5 466 470 1940587
16. The level of serum lipid, vitamin E and low density lipoprotein oxidation in Wilson's disease patients. M Rodo A Czonkowska M Pulawska M Swiderska B Tarnacka H Wehr, Europ J Neurol 2007 7 491 494
17. Zinc lowers high-density lipoprotein-cholesterol levels. PL Hooper L Visconti PJ Garry GE Johnson, Jama 1980 244 17 1960 1961 10.1001/jama.244.17. 1960 7420708 (Pubitemid 10014997)
18. Excessive intake of zinc impairs immune responses. RK Chandra, Jama 1984 252 11 1443 1446 10.1001/jama.252.11.1443 6471270 (Pubitemid 14037009)
19. Zinc supplements and serum lipids in young adult white males. MR Black D Medeiros E Brunett R Welke, Am J Clin Nutr 1988 47 6 970 975 3163879
20. Diagnosis and phenotypic classification of Wilson disease. P Ferenci K Caca G Loudianos G Mieli-Vergani S Tanner I Sternlieb M Schilsky D Cox F Berr, Liver Int 2003 23 3 139 142 10.1034/j.1600-0676.2003.00824.x 12955875 (Pubitemid 37265785)
21. Zinc Monotherapy is not as effective as chelating agents in treatment of Wilson disease. KH Weiss DN Gotthardt D Klemm U Merle D Ferenci-Foerster M Schaefer P Ferenci W Stremmel, Gastroenterology 2011 140 4 1189 1198 10.1053/j.gastro.2010.12.034 21185835